Everyone Already Knows Everything About Megacaps … But Not These Stocks
Stocks like Apple and Amazon are a like an open book everyone has already read. That’s why I get an edge researching this type of stock.
You've reached your free article limit
You've read 0 of 1 free Pro articles.
A standard piece of advice for investors is to do your homework. Sometimes it is put in the form of “know what you own.” That is rather vague, but what it usually means is to do fundamental work on the stock you want to buy. Learn the details of how a company operates. Look at the financial statements, revenue, margins, competitive position, the balance sheet, and what management says. The research can be a general overview or extremely detailed. The theory is that it gives you a greater understanding of the stock and that makes you a more confident investor.
What often happens instead is something behavioral economists call confirmation bias. It is the tendency to look only for information that supports a view you already hold. Rather than trying to find the flaw in a stock we want to buy, we focus on the positives. That is not fatal but it is common, and it gets worse the longer you own a stock and the more emotionally invested you become. The best defense against this behavior is simply being aware of the tendency and making an extra effort to stay objective.
Maintaining that objectivity is essential. Just as important, and far less discussed, is that fundamental research does two completely different jobs depending on what you are researching.
The Same Work, Two Different Purposes
A large cap with wide analyst coverage is a totally different animal from a small cap with limited institutional following. With a mega-cap stock, you are not going to learn something the market does not know. Fifty analysts have modeled every line of the income statement. The company holds quarterly calls attended by hundreds of professionals. Every strategic decision is dissected on television within an hour. You may reach a different conclusion than the consensus, and sometimes you will be right, but you will not have different information. Your research is producing an opinion, not an edge.
With a small cap, the situation reverses completely. The information is just as public and almost nobody has bothered to dig it out. Four firms might cover a company worth two billion dollars, and two of them have not updated their models in six months. Read the filings, listen to the call, understand the business, and it is entirely possible to know something that is not in the price. That is a pricing inefficiency, and it exists because of neglect rather than complexity.
So fundamental research is a powerful tool for small caps and a far less effective one for large, well-known stocks. Not because the fundamentals of a large company do not matter, but because they are already in the price and you are not going to know them better than the market does.
One of the primary reasons I prefer small-cap investing is that I can find an edge that I can never find with mega-cap names.
Why Do Any Research on a Megacap?
With a small cap, insightful fundamental work gives you a substantial advantage and a good reason to buy. You found something the market has not priced. In a megacap, the work is not going to uncover anything new. You do not buy Apple (AAPL) because you know something nobody else knows. You use your understanding of the business so that you can take advantage of mispricing if it does occur, and so that you have the confidence to navigate the volatility when the stock is falling and does not look like a compelling value.
If the only stocks I bought were the ones that looked cheap on fundamentals, I would almost never own a mega-cap stock. I have no edge in valuing these companies. I look at the multiple against the growth rate and all I see are expensive stocks. Apple is projected to have single-digit earnings and revenue growth next year and trades at a forward multiple in the mid-30s. That does not strike me as a compelling value, but there are still plenty of analysts who think it is a good buy.
I do not want to ignore names like that just because the valuation looks problematic. Megacaps are an asset class that does produce tradable moves constantly, and those moves are not valuation events. They are positioning events, visible to anyone watching the price action rather than the models.
What You Are Actually Trading
A large stock gets sold all the time for reasons that have nothing to do with the business. A sector rotation pulls money out of an entire group. A fund unwinds a position. A theme goes out of favor and every name attached to it goes down together. Traders reposition ahead of an event and the selling is mechanical rather than considered.
Those declines are visible and they eventually resolve. Money that left because of positioning comes back when the positioning is finished. That is a different kind of opportunity from a cheap stock nobody knows, and it is often easier to time, precisely because the valuation debate is so well understood that it is not what is driving the move.
Telling the Difference
The hard part with big caps is distinguishing a positioning event from actual deterioration, because on the first day they look identical. The test is whether anything happened at the company.
Amazon (AMZN) fell about 9% from its high in early August. In that stretch, there was no warning, no guidance change, no downgrade, no offering, and no news of any kind. What changed is that we entered the weakest part of the calendar and the large technology names started getting sold as a group. That is a positioning decline.
Meta Platforms (META) is the counterexample. It fell roughly 20% and it deserved to. Revenue grew and beat expectations, so the business was performing, but earnings missed and free cash flow collapsed. The spending stopped being a promise of future growth and showed up as a negative in the reported numbers. Something actually happened. Buying that decline because the stock was down 20% would have been buying a stock that got cheaper for a reason.
Apple is the third case and the most instructive. It beat on earnings, revenue, and iPhone sales, and the stock fell on guidance, with the company citing supply constraints from rising memory prices. Nothing was wrong with the business. Something was wrong with the input costs, and that is a condition rather than an event. It may persist for several quarters.
The three questions when a big cap breaks down are whether the business changed, whether the reported numbers changed, and whether an external condition changed. The fundamental research should be focused on those issues.
Permission, Not Reason
This is where fundamental research is of value in a large cap and it is different than the way most people view it. The quality of the business is not the reason to buy. A good business is a good business at any price on any day, which makes it an argument that can never be tested.
What the fundamental research does is make it safe to be the buyer while the stock is falling and the chart looks broken. Knowing that Amazon’s cloud business is accelerating does not make the stock cheap. It tells me the selling is about something other than the business, which is exactly what I need to know when I am buying weakness.
The weakness is the reason to trade the stock. The health of the business is the permission to trade it.
The Trade Has a Shape
A valuation thesis does not tell you when you are wrong. You bought it below what it is worth, and if it falls further, it is further below what it is worth, so you can hold forever because it is cheap. The position has no ending and no test. That is not a good investment.
A dislocation trade has both a testable thesis and a finite time frame. You have a view about why the selling is happening, a view about what would end it, and a rough window in which that should occur. If the reason resolves and the stock does not respond, you were wrong about something and you find that out. If the reason does not resolve, you were wrong about the cause and you find that out too.
That is a thesis that can fail, which is what makes it a trade rather than a hope.
Where the Research Actually Pays
None of this argues for owning megacaps as a core holding. I find fundamental research far more valuable in small companies nobody follows. That is where the opportunities live and where the work pays for itself directly rather than serving as a safety check.
The point is that fundamental research serves different purposes and you should be clear about which one you are pursuing. In a neglected company, the research is the edge. In a widely held one, the research is what lets you act when the price action gets ugly, and the edge comes from understanding why the selling is happening rather than from understanding the business better than anyone else.
Do your homework. Just make sure you are doing it for the right reason.
At the time of publication, DePorre had no position in any security menitoned.
